Unum Therapeutics Inc. (UMRX:NASDAQ) jumped higher at $2.2, a gain of 394.6%. On Thu 02 Jul 20, UMRX:NASDAQ hit a New 2-Week Intraday Low of $0.43. The stock appeared on our News Catalysts scanner on Mon 06 Jul 20 at 12:00 PM in the 'ACQUISITION' category. From Thu 18 Jun 20, the stock recorded 40.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About Unum Therapeutics Inc. (UMRX:NASDAQ)
Unum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient's immune system to cure cancer.
Top 10 Gainers:
- Unum Therapeutics Inc. (UMRX:NASDAQ), 394.6%
- Electrameccanica Vehicles Corp. (SOLO:NASDAQ), 64.54%
- AYRO (AYRO:NASDAQ), 63.61%
- CBAK Energy Technology, Inc. (CBAT:NASDAQ), 62.21%
- Blink Charging Co. (BLNK:NASDAQ), 59.09%
- Rosehill Resources Inc. (ROSE:NASDAQ), 57.58%
- Net Element, Inc. (NETE:NASDAQ), 45.72%
- Globalstar, Inc. (GSAT:NYSEMKT), 39.86%
- MOGU Inc. (MOGU:NYSE), 37.29%
- Gevo, Inc. (GEVO:NASDAQ), 34.54%